<link rel="stylesheet" href="http://raw.githubusercontent.com/sindresorhus/github-markdown-css/gh-pages/github-markdown.css">
<style>
    .markdown-body {
        min-width: 200px;
        max-width: 790px;
        margin: 0 auto;
        padding: 30px;
    }
</style>
<article class="markdown-body">

<h1>Artichokes and its effects on breast cancer</h1>

<ul id="knowledge-list">

  <li>
    Oral Capsol-TÂ® is well tolerated and, for ENOX2 presence in serum in the absence of clinical cancer symptoms, is consistently effective in reducing the serum ENOX2 levels to below detectable limits.
    <ul>
      <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901999/">Link to article</a></li>
      <li>Citation:</li>
      <ul>
        Clinical proteomics. Published 2014.
      </ul>
    </ul>
  </li>

  <li>
    The lack of randomized trials and the presence of confounding factors including smoking, physical activity, obesity and diabetes may often yield inconclusive results. Carefully designed randomized trials are recommended.
    <ul>
      <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819783/">Link to article</a></li>
      <li>Citation:</li>
      <ul>
        Journal of Gastrointestinal Oncology. Published December 2013.
      </ul>
    </ul>
  </li>

  <li>
    FKA managed to induce apoptosis and inhibit the metastatic process in two breast cancer cell lines, in vitro. Overall, FKA may serve as a promising candidate in the search of a new anti-cancer drug especially in halting the metastatic process but further in vivo evidence is needed.
    <ul>
      <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186755/">Link to article</a></li>
      <li>Citation:</li>
      <ul>
        PLoS ONE. Published 2014.
      </ul>
    </ul>
  </li>

</ul>

</article>
